MedTrace Logo

Contoura With Phorcides Compared to Wavefront Optimized LASIK

NCT05486546 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-04-26

No results posted yet for this study

Summary

Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.

Conditions

  • Myopia
  • Astigmatism

Interventions

PROCEDURE

Contoura with Phorcides

Participants that undergo LASIK surgery using Contoura with Phorcides Analytic Engine

DEVICE

WaveLight Wavefront Optimized

Participants that undergo LASIK surgery using WaveLight Wavefront Optimized

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY

  • Daniel Terveen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
38 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-15
Primary Completion
2023-09-01
Completion
2023-12-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05486546 on ClinicalTrials.gov